Our lab develops new minimally invasive image-guided cancer treatments:
- Methods for improving the anti-tumor immune response after embolization or ablation.
- Genetic, imaging, and other tests to predict response after embolization or ablation.
- New devices for endoluminal ablation (ureter, bile ducts, bronchi, bowel).
- New intra-arterial therapies for liver and pancreatic cancer.
- Transgenic pig model for liver and pancreatic cancer.
- Imaging technologies for rapid diagnosis from biopsy specimens.
- Outcomes after cancer interventions.
- Evidence-based cancer imaging.
- Erinjeri JP et al. “Image-guided Thermal Ablation of Tumors Increases the Plasma Level of Interleukin-6 and Interleukin-10.” Journal of Vascular and Interventional Radiology. 2013. 24(8): 1105-12.
- Ziv E et al “Lung Adenocarcinoma: Predictive Value of KRAS Mutation Status in Assessing Local Recurrence in Patients Undergoing Image-guided Ablation.” Radiology 2017. 282(1): 251-8.
- Thompson family foundation grant. (Drs. Yarmohammadi, Srimathveeravalli, and Boas, in collaboration with David Kelsen, Avigdor Scherz, and others)
- Department of Defense, Peer Reviewed Cancer Research Program grant (Drs. Solomon, Brown, and Boas, in collaboration with Drs. Schook and Gaba at the University of Illinois)
- RSNA Research Scholar grant (Dr Yarmohammadi)
- Ernest J Ring Career Development Grant award from the Society of Interventional Radiology (Dr Yarmohammadi)
- Ernest J Ring Career Development Grant award from the Society of Interventional Radiology (Dr Srimathveeravalli)